TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
2 hedge funds and large institutions have $153K invested in TITAN PHARMACEUTICAL INC in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
59% less capital invested
Capital invested by funds: $377K → $153K (-$224K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$103K |
TTP Hedge Fund Activity: Q4 2016 in Review
2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q4 2016, worth a combined $153K — down 59% from $377K a quarter earlier.
Fund positioning in TTP was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Gagnon Securities, cutting an estimated $103K.
- 2 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $153K of TITAN PHARMACEUTICAL INC stock for Q4 2016, down 59% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q4 2016 and 0 closed out.
- The largest TITAN PHARMACEUTICAL INC seller in Q4 2016 was Gagnon Securities, an estimated $103K sold.
Based on aggregated 13F filings for Q4 2016.